ARTICLE | Clinical News
Votrient pazopanib regulatory update
August 13, 2012 7:00 AM UTC
The European Commission approved Votrient pazopanib from GlaxoSmithKline to treat advanced soft tissue sarcoma in patients who received prior chemotherapy or who have progressed in the last 12 months ...